Related Research Articles
Lassa fever,also known as Lassa hemorrhagic fever,is a type of viral hemorrhagic fever caused by the Lassa virus. Many of those infected by the virus do not develop symptoms. When symptoms occur they typically include fever,weakness,headaches,vomiting,and muscle pains. Less commonly there may be bleeding from the mouth or gastrointestinal tract. The risk of death once infected is about one percent and frequently occurs within two weeks of the onset of symptoms. Of those who survive,about a quarter have hearing loss,which improves within three months in about half of these cases.
Marburg virus disease is a viral hemorrhagic fever in human and non-human primates caused by either of the two Marburgviruses:Marburg virus (MARV) and Ravn virus (RAVV). Its clinical symptoms are very similar to those of Ebola virus disease (EVD).
The genus Ebolavirus is a virological taxon included in the family Filoviridae,order Mononegavirales. The members of this genus are called ebolaviruses,and encode their genome in the form of single-stranded negative-sense RNA. The six known virus species are named for the region where each was originally identified:Bundibugyo ebolavirus,Reston ebolavirus,Sudan ebolavirus,TaïForest ebolavirus,Zaire ebolavirus,and Bombali ebolavirus. The last is the most recent species to be named and was isolated from Angolan free-tailed bats in Sierra Leone. Each species of the genus Ebolavirus has one member virus,and four of these cause Ebola virus disease (EVD) in humans,a type of hemorrhagic fever having a very high case fatality rate. The Reston virus has caused EVD in other primates. Zaire ebolavirus has the highest mortality rate of the ebolaviruses and is responsible for the largest number of outbreaks of the six known species of the genus,including the 1976 Zaire outbreak and the outbreak with the most deaths (2014).
Lassa mammarenavirus (LASV) is an arenavirus that causes Lassa hemorrhagic fever,a type of viral hemorrhagic fever (VHF),in humans and other primates. Lassa mammarenavirus is an emerging virus and a select agent,requiring Biosafety Level 4-equivalent containment. It is endemic in West African countries,especially Sierra Leone,the Republic of Guinea,Nigeria,and Liberia,where the annual incidence of infection is between 300,000 and 500,000 cases,resulting in 5,000 deaths per year.
An arenavirus is a bi- or trisegmented ambisense RNA virus that is a member of the family Arenaviridae. These viruses infect rodents and occasionally humans. A class of novel,highly divergent arenaviruses,properly known as reptarenaviruses,have also been discovered which infect snakes to produce inclusion body disease,mostly in boa constrictors. At least eight arenaviruses are known to cause human disease. The diseases derived from arenaviruses range in severity. Aseptic meningitis,a severe human disease that causes inflammation covering the brain and spinal cord,can arise from the lymphocytic choriomeningitis virus. Hemorrhagic fever syndromes,including Lassa fever,are derived from infections such as Guanarito virus,Junin virus,Lassa virus,Lujo virus,Machupo virus,Sabia virus,or Whitewater Arroyo virus. Because of the epidemiological association with rodents,some arenaviruses and bunyaviruses are designated as roboviruses.
Viral hemorrhagic fevers (VHFs) are a diverse group of animal and human illnesses. VHFs may be caused by five distinct families of RNA viruses:the families Filoviridae,Flaviviridae,Rhabdoviridae,and several member families of the Bunyavirales order such as Arenaviridae,and Hantaviridae. All types of VHF are characterized by fever and bleeding disorders and all can progress to high fever,shock and death in many cases. Some of the VHF agents cause relatively mild illnesses,such as the Scandinavian nephropathia epidemica,while others,such as Ebola virus,can cause severe,life-threatening disease.
Lymphocytic choriomeningitis (LCM) is a rodent-borne viral infectious disease that presents as aseptic meningitis,encephalitis or meningoencephalitis. Its causative agent is lymphocytic choriomeningitis mammarenavirus (LCMV),a member of the family Arenaviridae. The name was coined by Charles Armstrong in 1934.
Venezuelan hemorrhagic fever (VHF) is a zoonotic human illness first identified in 1989. The disease is most prevalent in several rural areas of central Venezuela and is caused by Guanarito mammarenavirus (GTOV) which belongs to the Arenaviridae family. The short-tailed cane mouse is the main host for GTOV which is spread mostly by inhalation of aerosolized droplets of saliva,respiratory secretions,urine,or blood from infected rodents. Person-to-person spread is possible,but uncommon.
Orungo virus (ORUV) is an arbovirus of the genus Orbivirus,the subfamily Sedoreovirinae and the family Reoviridae. There are four known subtypes of Orungo virus designated Orungo-1 (ORUV-1),Orungo-2 (ORUV-2),Orungo-3 (ORUV-3),and Orungo-4 (ORUV-4). It was first isolated by the Uganda Virus Research Institute in Entebbe,Uganda by Oyewale Tomori and colleagues. Antibodies to the virus have been found in humans,monkeys,sheep,and cattle.
An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently,and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal,as well as clinical. EIDs have been increasing steadily since at least 1940.
Clarence James Peters,Jr is a physician,field virologist and former U.S. Army colonel. He is noted for his efforts in trying to stem epidemics of exotic infectious diseases such as the Ebola virus,Hanta virus and Rift Valley fever (RVF). He is an eminent authority on the virology,pathogenesis and epidemiology of hemorrhagic fever viruses.
Aniru Sahib Sahib Conteh was a Sierra Leonean physician and expert on the clinical treatment of Lassa fever,a viral hemorrhagic fever endemic to West Africa caused by the Lassa virus. Conteh studied medicine at the University of Ibadan in Nigeria and taught at Ibadan Teaching Hospital. He later returned to Sierra Leone where he joined the Centers for Disease Control and Prevention (CDC) Lassa fever program at Nixon Methodist Hospital in Segbwema,first as superintendent and then as clinical director.
Marburg virus (MARV) is a hemorrhagic fever virus of the Filoviridae family of viruses and a member of the species Marburg marburgvirus,genus Marburgvirus. It causes Marburg virus disease in primates,a form of viral hemorrhagic fever. The virus is considered to be extremely dangerous. The World Health Organization (WHO) rates it as a Risk Group 4 Pathogen. In the United States,the National Institute of Allergy and Infectious Diseases ranks it as a Category A Priority Pathogen and the Centers for Disease Control and Prevention lists it as a Category A Bioterrorism Agent. It is also listed as a biological agent for export control by the Australia Group.
In 2014,an outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) occurred. Genome sequencing has shown that this outbreak was not related to the 2014–15 West Africa Ebola virus epidemic,but was of the same EBOV species. It began in August 2014 and was declared over in November of that year,after 42 days without any new cases. This is the 7th outbreak there,three of which occurred during the period of Zaire.
There is a cure for the Ebola virus disease that is currently approved for market the US government has inventory in the Strategic National Stockpile. For past and current Ebola epidemics,treatment has been primarily supportive in nature.
The Democratic Republic of the Congo (DRC) was identified by the World Health Organization (WHO) on 11 May 2017 as having one Ebola-related death.
Jean-Paul Joseph Gonzalez is a French virologist. He graduated from the Medical School of Bordeaux University France.
Patricia Ann Webb was a microbiologist known for her work in characterising and classifying severe contagious diseases including Machupo,Lassa and Ebola viruses.
On 7 February 2021,the Congolese health ministry announced that a new case of Ebola near Butembo,North Kivu had been detected the previous day. The case was a 42-year-old woman who had symptoms of Ebola in Biena on 1 February 2021. A few days after,she died in a hospital in Butembo. The WHO said that more than 70 people who had contact with the woman had been tracked.
References
- ↑ "PROFESSOR OYEWALE TOMORI". Nigerian Young Academy. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
- ↑ Achieving Sustainable Global Capacity for Surveillance and Response to ... National Research Council. 2008. p. 98. ISBN 978-0309128186.
- ↑ Jide Osuntokun (September 19, 2013). "Redeemer's University's 5th Convocation". The Nation Online Nigeria. Retrieved 2019-09-16.
- ↑ Biodun Oyeleye (September 18, 2014). "Ebola: Time to reactivate surveillance for infections, says virologist". New Telegraph. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
- ↑ "Tomori Elected Chair of West Africa National Academy of Sciences". The Nation.
- ↑ "Oyewale Tomori". Bulletin of the Atomic Scientists.
- ↑ Akintayo Eribake (July 30, 2014). "Ebola: Nigeria is not out of the woods yet — Prof. Tomori". Vanguard News. Retrieved 2019-09-16.
- ↑ "What can Nigeria's Ebola experience teach the world?". The Guardian . October 7, 2014. Retrieved 2019-09-16.
- ↑ Kupferschmidt, Kai (2014). "Nigerian virologist delivers scathing analysis of Africa's response to Ebola" . Retrieved May 30, 2020.
- ↑ "Tomori's appraisal of Nigerian scientists". The Punch - Nigeria's Most Widely Read Newspaper. May 23, 2013. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
- ↑ Committee Biographies - Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin - NCBI Bookshelf. National Academies Press (US). 2008.
- ↑ "WHO - Professor Oyewale Tomori". World Health Organization. Archived from the original on October 26, 2014. Retrieved 2019-09-16.
- ↑ Strategic Advisory Group of Experts (SAGE) (September 1, 2010). "Immunization, Vaccines and Biologicals". WHO. Archived from the original on October 26, 2014. Retrieved May 30, 2020.
- ↑ "Tomori takes over as Nigerian Academy of Science president". Daily Independent, Nigerian Newspaper. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
- ↑ "Prof. Tomori advocates for One Health Workforce". University of Nigeria. Archived from the original on October 26, 2014. Retrieved 2014-10-26.
- ↑ "National Academy of Medicine Elects 79 New Members | National Academy of Medicine". nam.edu. October 17, 2016. Retrieved 2019-09-16.
- ↑ "Fellows of ASTMH (FASTMH)" . Retrieved 2019-09-16.
- ↑ Khan, Ali S.; Tshioko, F. Kweteminga; Heymann, David L.; Le Guenno, Bernard; Nabeth, Pierre; Kerstiëns, Barbara; Fleerackers, Yon; Kilmarx, Peter H.; Rodier, Guenael R.; Nkuku, Okumi; Rollin, Pierre E. (1999-02-01). "The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995". The Journal of Infectious Diseases. 179 (Supplement_1): S76–S86. doi: 10.1086/514306 . ISSN 0022-1899. PMID 9988168.
- ↑ Robertson, Susan E.; Hull, B. P.; Tomori, O.; Bele, O.; LeDuc, J. W.; Esteves, K. (1996). "Yellow Fever: a decade of reemergence". JAMA. 276 (14): 1157–62. doi:10.1001/jama.1996.03540140045025. ISSN 0098-7484. PMID 8827969.
- ↑ Fisher-Hoch, S P; Tomori, O; Nasidi, A; Perez-Oronoz, G I; Fakile, Y; Hutwagner, L; McCormick, J B (1995-09-30). "Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice". BMJ. 311 (7009): 857–859. doi:10.1136/bmj.311.7009.857. ISSN 0959-8138. PMC 2550858 . PMID 7580496.
- ↑ Jentes, Emily S; Poumerol, Gilles; Gershman, Mark D; Hill, David R; Lemarchand, Johan; Lewis, Rosamund F; Staples, J Erin; Tomori, Oyewale; Wilder-Smith, Annelies; Monath, Thomas P (2011). "The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever". The Lancet Infectious Diseases. 11 (8): 622–632. doi:10.1016/S1473-3099(11)70147-5. PMID 21798462.
- ↑ Buchmeier, Michael J.; Lewicki, Hanna A.; Tomori, Oyewale; Oldstone, Michael B.A. (1981). "Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: Generation, characterization, and cross-reactivity with other arenaviruses". Virology. 113 (1): 73–85. doi:10.1016/0042-6822(81)90137-9. PMID 6267791.
- ↑ Tomori, Oyewale (2004). "Yellow Fever: The Recurring Plague". Critical Reviews in Clinical Laboratory Sciences. 41 (4): 391–427. doi:10.1080/10408360490497474. ISSN 1040-8363. PMID 15487593. S2CID 13559157.
- ↑ Adebamowo, Clement; Bah-Sow, Oumou; Binka, Fred; Bruzzone, Roberto; Caplan, Arthur; Delfraissy, Jean-François; Heymann, David; Horby, Peter; Kaleebu, Pontiano; Tamfum, Jean-Jacques Muyembe; Olliaro, Piero (2014). "Randomised controlled trials for Ebola: practical and ethical issues". The Lancet. 384 (9952): 1423–1424. doi:10.1016/s0140-6736(14)61734-7. ISSN 0140-6736. PMC 4392883 . PMID 25390318.
- ↑ Bausch, Daniel G.; Borchert, Matthias; Grein, Thomas; Roth, Cathy; Swanepoel, Robert; Libande, Modeste L.; Talarmin, Antoine; Bertherat, Eric; Muyembe-Tamfum, Jean-Jacques; Tugume, Ben; Colebunders, Robert (2003). "Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo". Emerging Infectious Diseases. 9 (12): 1531–1537. doi: 10.3201/eid0912.030355 . ISSN 1080-6040. PMC 3034318 . PMID 14720391.
- ↑ Fasina, F O; Shittu, A; Lazarus, D; Tomori, O; Simonsen, L; Viboud, C; Chowell, G (2014-10-09). "Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014". Eurosurveillance. 19 (40): 20920. doi: 10.2807/1560-7917.es2014.19.40.20920 . hdl: 2263/42723 . ISSN 1560-7917. PMID 25323076.
- ↑ Burns, C. C.; Shaw, J.; Jorba, J.; Bukbuk, D.; Adu, F.; Gumede, N.; Pate, M. A.; Abanida, E. A.; Gasasira, A.; Iber, J.; Chen, Q. (2013-02-13). "Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria". Journal of Virology. 87 (9): 4907–4922. doi: 10.1128/jvi.02954-12 . ISSN 0022-538X. PMC 3624331 . PMID 23408630.
- ↑ Tomori, Oyewale; Sorungbe, Akanni; Fabiyi, Akinyele; McCormick, Joseph B.; Smith, Ademola (1988-03-01). "Viral Hemorrhagic Fever Antibodies in Nigerian Populations". The American Journal of Tropical Medicine and Hygiene. 38 (2): 407–410. doi:10.4269/ajtmh.1988.38.407. ISSN 0002-9637. PMID 3128130.
- ↑ Nasidi, A.; Monath, T.P.; DeCock, K.; Tomori, O.; Cordellier, R.; Olaleye, O.D.; Harry, T.O.; Adeniyi, J.A.; Sorungbe, A.O.; Ajose-Coker, A.O.; van Der Laan, G. (1989). "Urban yellow fever epidemic in western Nigeria, 1987". Transactions of the Royal Society of Tropical Medicine and Hygiene. 83 (3): 401–406. doi:10.1016/0035-9203(89)90518-x. ISSN 0035-9203. PMID 2617590.
- ↑ Carroll, Dennis; Daszak, Peter; Wolfe, Nathan D.; Gao, George F.; Morel, Carlos M.; Morzaria, Subhash; Pablos-Méndez, Ariel; Tomori, Oyewale; Mazet, Jonna A. K. (2018-02-22). "The Global Virome Project". Science. 359 (6378): 872–874. doi:10.1126/science.aap7463. ISSN 0036-8075. PMID 29472471. S2CID 3543474.
- ↑ Johnson, K. M.; Taylor, P.; Tomori, O.; Elliott, L. H. (1981-11-01). "Recovery of a Lassa-Related Arenavirus in Zimbabwe". The American Journal of Tropical Medicine and Hygiene. 30 (6): 1291–1293. doi:10.4269/ajtmh.1981.30.1291. ISSN 0002-9637. PMID 7034562.
- ↑ Gostin, Lawrence O.; Tomori, Oyewale; Wibulpolprasert, Suwit; Jha, Ashish K.; Frenk, Julio; Moon, Suerie; Phumaphi, Joy; Piot, Peter; Stocking, Barbara; Dzau, Victor J.; Leung, Gabriel M. (2016-05-19). "Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola". PLOS Medicine. 13 (5): e1002042. doi: 10.1371/journal.pmed.1002042 . ISSN 1549-1676. PMC 4873000 . PMID 27195954.
- ↑ Siddle, Katherine J.; Eromon, Philomena; Barnes, Kayla G.; Mehta, Samar; Oguzie, Judith U.; Odia, Ikponmwosa; Schaffner, Stephen F.; Winnicki, Sarah M.; Shah, Rickey R.; Qu, James; Wohl, Shirlee (2018). "Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018". New England Journal of Medicine. 379 (18): 1745–1753. doi: 10.1056/nejmoa1804498 . ISSN 0028-4793. PMC 6181183 . PMID 30332564.
- ↑ Advances in virus research. Volume 53. Maramorosch, Karl., Murphy, Frederick A., Shatkin, Aaron J. San Diego: Academic Press. 1999. ISBN 0-12-039853-2. OCLC 646758896.
{{cite book}}: CS1 maint: others (link) - ↑ Buchmeier, Michael J.; Lewicki, Hanna A.; Tomori, Oyewale; Johnson, Karl M. (1980). "Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses". Nature. 288 (5790): 486–487. doi:10.1038/288486a0. ISSN 0028-0836. PMID 6160402. S2CID 23522940.
- ↑ Sridhar, Shruti; Greenwood, Brian; Head, Christopher; Plotkin, Stanley A; Sáfadi, Marco A; Saha, Samir; Taha, Muhamed-Kheir; Tomori, Oyewale; Gessner, Bradford D (2015). "Global incidence of serogroup B invasive meningococcal disease: a systematic review". The Lancet Infectious Diseases. 15 (11): 1334–1346. doi:10.1016/s1473-3099(15)00217-0. ISSN 1473-3099. PMID 26453240.
| International | |
|---|---|
| National | |
